Also, this molecule significantly downregulated the expression of the pluripotency gene, SOX2 (p < 0.001), and caused the overexpression of CASP3 (a marker of late apoptosis) (p < 0.01, Fig. 5b) in all breast cancer cells. This evidence concerns the gene SOX2 and breast carcinoma.